F star Therapeutics Inc
Officers & Directors
- Chairman of the Board - John Haurum: John Haurum co-founded F-star Therapeutics in 2006 and currently serves as Chairman of the Board. Prior to F-star, he was the CEO of Symphogen, a private biotechnology company. He has also held various leadership roles at Novo Nordisk, including Vice President and Head of Research.
- Chief Executive Officer - Eliot Forster: Eliot Forster joined F-star in 2010 and was appointed CEO in 2015. He has over 25 years of experience in the biotech industry, having previously held senior roles at both Pfizer and Solvay Pharmaceuticals. He has also served as CEO of Immunocore and Medikidz.
- Chief Financial Officer - Louis Kayitalire: Louis Kayitalire joined F-star as CFO in 2019. He has over 15 years of experience in finance and accounting, having previously worked at PwC and BDO. He has also held senior finance roles at various biotech companies.
- Chief Medical Officer - Neil Brewis: Neil Brewis joined F-star as CMO in 2019. He has over 20 years of experience in drug development, having previously worked at Pfizer and AstraZeneca. He has also held leadership roles at several biotech companies.
- Chief Scientific Officer - Ab also Khleif: Ab als Khleif joined F-star as CSO in 2019. He has over 15 years of experience in drug discovery and development, having previously worked at Eli Lilly and Ionis Pharmaceuticals. He has also held senior roles at several biotech companies.
- Board Member - Tim Haines: Tim Haines is a founding partner of Abingworth, a venture capital firm that has invested in F-star since its inception. He has over 25 years of experience in the biotech industry and has served on the boards of numerous biotech companies.
- Board Member - Klaus Breiner: Klaus Breiner is a Managing Director at Aescap Ventures, a healthcare-focused venture capital firm that has invested in F-star. He has over 20 years of experience in the biotech industry and has served on the boards of several biotech companies.
- Board Member - Frank Nestle: Frank Nestle is a Professor of Immunology at King's College London and a scientific co-founder of F-star. He has over 25 years of experience in biomedical research and has authored over 130 publications in the fields of immunology and cancer biology.
F star Therapeutics Inc currently has 56 employees.
|
